JP Morgan: MENGNIU DAIRY (02319) sees a turnaround in sales and profit this year, maintaining a "buy" rating.
The bank maintains its "buy" rating on Mengniu, with the target price lowered from 22 Hong Kong dollars to 20 Hong Kong dollars, expecting strong sales during the Chinese New Year to serve as a short-term catalyst.
JPMorgan Chase released a research report stating that it maintained a "hold" rating on MENGNIU DAIRY (02319), expecting strong Lunar New Year sales this year to serve as a short-term catalyst.
The bank expects sales and adjusted profits to increase by 2% and 17% respectively compared to last year. It believes that the competitive environment this year will be more benign, despite overall moderate demand and competition from other beverage categories such as coffee and tea. The company is actively optimizing its product portfolio and expanding into new channels to regain market share.
Related Articles

HK Stock Market Move | Oil and oil service stocks fell in early trading, with the ongoing turmoil in Iran continuing to disrupt oil prices. Institutions warn to be wary of potential geopolitical event reversals.

China Galaxy Securities: Maintains "buy" rating for ANTA SPORTS (02020) as acquisition of Puma equity enhances globalization strategy.

HK Stock Market Move | ZJLD (06979) rose more than 5%, institutions believe that the liquor sector may usher in a ten-year investment opportunity at the bottom.
HK Stock Market Move | Oil and oil service stocks fell in early trading, with the ongoing turmoil in Iran continuing to disrupt oil prices. Institutions warn to be wary of potential geopolitical event reversals.

China Galaxy Securities: Maintains "buy" rating for ANTA SPORTS (02020) as acquisition of Puma equity enhances globalization strategy.

HK Stock Market Move | ZJLD (06979) rose more than 5%, institutions believe that the liquor sector may usher in a ten-year investment opportunity at the bottom.

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


